| Dr Helen Bachvarov Gelly, MD | |
|
61 Whitcher St Ne, Suite 2150, Marietta, GA 30060-1176 | |
| (770) 422-4268 | |
| (770) 422-2950 |
| Full Name | Dr Helen Bachvarov Gelly |
|---|---|
| Gender | Female |
| Speciality | Undersea And Hyperbaric Medicine |
| Experience | 43 Years |
| Location | 61 Whitcher St Ne, Marietta, Georgia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467565481 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2083P0011X | Preventive Medicine - Undersea And Hyperbaric Medicine | 023892 (Georgia) | Primary |
| 163WW0000X | Registered Nurse - Wound Care | 023892 (Georgia) | Secondary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hyperbaric Physicians Of Georgia | 1052300076 | 7 |
| Cobb Hyperbaric Medicine Inc | 8325350499 | 4 |
News Archive
The chairman of the BMA in Scotland has this week written to the Presiding Officer suggesting that the Scottish Parliament smoking room for staff and MSPs be closed and replaced with a drop in smoking cessation support centre for staff and MSPs who wish to give up the habit.
Mersana Therapeutics today announced the initiation of a Phase 1b extension study with its lead cancer product, XMT-1001, a novel DNA topoisomerase I inhibitor based on the company's Fleximer® polymer conjugate platform, in second-line gastric cancer and second-/third-line non-small cell lung cancer. The study will be carried out in 10 clinical centers in the US.
Associates of Cape Cod, Inc., (ACC) is proud to introduce its NEW CHROMOGENIC ENDOTOXIN DETECTION SYSTEM incorporating the enhanced Pyrochrome® chromogenic reagent and the new-to-market Pyros Kinetix® Flex Incubating Kinetic tube reader. This system offers our customers diverse options for conducting endotoxin testing.
Complex heart imaging can increase cancer risks for children throughout their lifetime, according to a new study co-authored by Le Bonheur Cardiologist Jason Johnson, MD, MHS. The study, which appears in the June 9, 2014 issue of the American Heart Association's journal Circulation, is the first in which researchers quantified cumulative radiation doses in pediatric heart patients and predicted lifetime cancer risks based on the types of exposures.
› Verified 6 days ago
| Entity Name | Hyperbaric Physicians Of Georgia |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346300555 PECOS PAC ID: 1052300076 Enrollment ID: O20040506000941 |
News Archive
The chairman of the BMA in Scotland has this week written to the Presiding Officer suggesting that the Scottish Parliament smoking room for staff and MSPs be closed and replaced with a drop in smoking cessation support centre for staff and MSPs who wish to give up the habit.
Mersana Therapeutics today announced the initiation of a Phase 1b extension study with its lead cancer product, XMT-1001, a novel DNA topoisomerase I inhibitor based on the company's Fleximer® polymer conjugate platform, in second-line gastric cancer and second-/third-line non-small cell lung cancer. The study will be carried out in 10 clinical centers in the US.
Associates of Cape Cod, Inc., (ACC) is proud to introduce its NEW CHROMOGENIC ENDOTOXIN DETECTION SYSTEM incorporating the enhanced Pyrochrome® chromogenic reagent and the new-to-market Pyros Kinetix® Flex Incubating Kinetic tube reader. This system offers our customers diverse options for conducting endotoxin testing.
Complex heart imaging can increase cancer risks for children throughout their lifetime, according to a new study co-authored by Le Bonheur Cardiologist Jason Johnson, MD, MHS. The study, which appears in the June 9, 2014 issue of the American Heart Association's journal Circulation, is the first in which researchers quantified cumulative radiation doses in pediatric heart patients and predicted lifetime cancer risks based on the types of exposures.
› Verified 6 days ago
| Entity Name | Hyperbaric Medicine Of North Atlanta |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578703773 PECOS PAC ID: 5991017055 Enrollment ID: O20150701001704 |
News Archive
The chairman of the BMA in Scotland has this week written to the Presiding Officer suggesting that the Scottish Parliament smoking room for staff and MSPs be closed and replaced with a drop in smoking cessation support centre for staff and MSPs who wish to give up the habit.
Mersana Therapeutics today announced the initiation of a Phase 1b extension study with its lead cancer product, XMT-1001, a novel DNA topoisomerase I inhibitor based on the company's Fleximer® polymer conjugate platform, in second-line gastric cancer and second-/third-line non-small cell lung cancer. The study will be carried out in 10 clinical centers in the US.
Associates of Cape Cod, Inc., (ACC) is proud to introduce its NEW CHROMOGENIC ENDOTOXIN DETECTION SYSTEM incorporating the enhanced Pyrochrome® chromogenic reagent and the new-to-market Pyros Kinetix® Flex Incubating Kinetic tube reader. This system offers our customers diverse options for conducting endotoxin testing.
Complex heart imaging can increase cancer risks for children throughout their lifetime, according to a new study co-authored by Le Bonheur Cardiologist Jason Johnson, MD, MHS. The study, which appears in the June 9, 2014 issue of the American Heart Association's journal Circulation, is the first in which researchers quantified cumulative radiation doses in pediatric heart patients and predicted lifetime cancer risks based on the types of exposures.
› Verified 6 days ago
| Entity Name | Cobb Hyperbaric Medicine Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043376452 PECOS PAC ID: 8325350499 Enrollment ID: O20150701002163 |
News Archive
The chairman of the BMA in Scotland has this week written to the Presiding Officer suggesting that the Scottish Parliament smoking room for staff and MSPs be closed and replaced with a drop in smoking cessation support centre for staff and MSPs who wish to give up the habit.
Mersana Therapeutics today announced the initiation of a Phase 1b extension study with its lead cancer product, XMT-1001, a novel DNA topoisomerase I inhibitor based on the company's Fleximer® polymer conjugate platform, in second-line gastric cancer and second-/third-line non-small cell lung cancer. The study will be carried out in 10 clinical centers in the US.
Associates of Cape Cod, Inc., (ACC) is proud to introduce its NEW CHROMOGENIC ENDOTOXIN DETECTION SYSTEM incorporating the enhanced Pyrochrome® chromogenic reagent and the new-to-market Pyros Kinetix® Flex Incubating Kinetic tube reader. This system offers our customers diverse options for conducting endotoxin testing.
Complex heart imaging can increase cancer risks for children throughout their lifetime, according to a new study co-authored by Le Bonheur Cardiologist Jason Johnson, MD, MHS. The study, which appears in the June 9, 2014 issue of the American Heart Association's journal Circulation, is the first in which researchers quantified cumulative radiation doses in pediatric heart patients and predicted lifetime cancer risks based on the types of exposures.
› Verified 6 days ago
| Entity Name | North Georgia Center For Hyperbaric Medicine And Wound Care , Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447499413 PECOS PAC ID: 8325350093 Enrollment ID: O20150709000474 |
News Archive
The chairman of the BMA in Scotland has this week written to the Presiding Officer suggesting that the Scottish Parliament smoking room for staff and MSPs be closed and replaced with a drop in smoking cessation support centre for staff and MSPs who wish to give up the habit.
Mersana Therapeutics today announced the initiation of a Phase 1b extension study with its lead cancer product, XMT-1001, a novel DNA topoisomerase I inhibitor based on the company's Fleximer® polymer conjugate platform, in second-line gastric cancer and second-/third-line non-small cell lung cancer. The study will be carried out in 10 clinical centers in the US.
Associates of Cape Cod, Inc., (ACC) is proud to introduce its NEW CHROMOGENIC ENDOTOXIN DETECTION SYSTEM incorporating the enhanced Pyrochrome® chromogenic reagent and the new-to-market Pyros Kinetix® Flex Incubating Kinetic tube reader. This system offers our customers diverse options for conducting endotoxin testing.
Complex heart imaging can increase cancer risks for children throughout their lifetime, according to a new study co-authored by Le Bonheur Cardiologist Jason Johnson, MD, MHS. The study, which appears in the June 9, 2014 issue of the American Heart Association's journal Circulation, is the first in which researchers quantified cumulative radiation doses in pediatric heart patients and predicted lifetime cancer risks based on the types of exposures.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Helen Bachvarov Gelly, MD 1341 Canton Rd, Suite A, Marietta, GA 30066-6056 Ph: (770) 422-0517 | Dr Helen Bachvarov Gelly, MD 61 Whitcher St Ne, Suite 2150, Marietta, GA 30060-1176 Ph: (770) 422-4268 |
News Archive
The chairman of the BMA in Scotland has this week written to the Presiding Officer suggesting that the Scottish Parliament smoking room for staff and MSPs be closed and replaced with a drop in smoking cessation support centre for staff and MSPs who wish to give up the habit.
Mersana Therapeutics today announced the initiation of a Phase 1b extension study with its lead cancer product, XMT-1001, a novel DNA topoisomerase I inhibitor based on the company's Fleximer® polymer conjugate platform, in second-line gastric cancer and second-/third-line non-small cell lung cancer. The study will be carried out in 10 clinical centers in the US.
Associates of Cape Cod, Inc., (ACC) is proud to introduce its NEW CHROMOGENIC ENDOTOXIN DETECTION SYSTEM incorporating the enhanced Pyrochrome® chromogenic reagent and the new-to-market Pyros Kinetix® Flex Incubating Kinetic tube reader. This system offers our customers diverse options for conducting endotoxin testing.
Complex heart imaging can increase cancer risks for children throughout their lifetime, according to a new study co-authored by Le Bonheur Cardiologist Jason Johnson, MD, MHS. The study, which appears in the June 9, 2014 issue of the American Heart Association's journal Circulation, is the first in which researchers quantified cumulative radiation doses in pediatric heart patients and predicted lifetime cancer risks based on the types of exposures.
› Verified 6 days ago
Dr. Reda Coston, LMP, D.SC, PSYD/PH.D Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 2480 Windy Hill Rd Se, Suite 206, Marietta, GA 30067 Phone: 855-525-1011 Fax: 770-953-0074 | |
Walter B Wildstein, M.D. Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 220 Cobb Pkwy N, Suite 400, Marietta, GA 30062 Phone: 615-778-4066 | |
Kenya Chantel Miles, M.D. Preventive Medicine Medicare: Medicare Enrolled Practice Location: 3747 Roswell Rd Ste 204, Marietta, GA 30062 Phone: 470-956-4360 | |
Ms. Tamika A Jones, Preventive Medicine Medicare: Accepting Medicare Assignments Practice Location: 55 Whitcher St Ne, Marietta, GA 30060 Phone: 770-428-0462 | |
Dr. Stephen Chacko Jacob, M.D. Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 3535 Roswell Rd Ste 40, Marietta, GA 30062 Phone: 678-224-5334 | |
Alejandro R Alam-gonzalez, M.D. Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 220 Cobb Pkwy N, Suite 400, Marietta, GA 30062 Phone: 615-778-4066 |